Methodist Health System — Dallas, Texas

Methodist Health System is a clinical research site located in Dallas, Texas, United States.

Crixeo Clinical Trials Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.

Methodist Health System has participated in 12 clinical trials with 4 currently active.

Therapeutic areas: Localized Non-Resectable Adult Liver Carcinoma, Acute Pancreatitis (AP), Diabetes.

Sponsors: Vanderbilt-Ingram Cancer Center, Methodist Health System, University of Texas at Austin.

Sponsor Feasibility Report

Trust Score: 76/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Methodist Health System?

Methodist Health System has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Methodist Health System conducted?

Methodist Health System has 12 clinical trials on record, with 4 currently active. Their work covers Localized Non-Resectable Adult Liver Carcinoma, Acute Pancreatitis (AP), Diabetes.

Is Methodist Health System accredited by Crixeo Clinical Trials?

Methodist Health System has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Methodist Health System?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.